Anti-cancer treatments with anti-EGFR antibodies having a low fucosylation

• 收藏
• 分享

专利权人:

Glycotope GmbH

发明人:

Goletz, Steffen,Danielczyk, Antje

申请号：

AU2014257650

公开号：

AU2014257650A1

申请日:

2014.04.22

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

The present invention pertains to the field of cancer therapy using anti-cancer antibodies. The medical use of anti-EGFR antibodies having improved glycosylation characteristics, in particular a reduced fucosylation, is provided which show anti-cancer efficacy and an improved adverse side effect profile.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/